Lipoprotein(a) and vitamin C impair development of breast cancer tumors in Lp(a)+; Gulo−/− mice
Authors:
Open Access
- 1 July 2016
- journal article
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 49 (3) , 895-902
Abstract
Cancer progression is characterized by loss of extracellular matrix (ECM) integrity, which is a precondition for tumor growth and metastasis. In order to elucidate the precise mechanisms of ECM degradation in cancer we used a genetically modified mouse mimicking two distinct human metabolic features associated with carcinogenesis, the lack of endogenous vitamin C synthesis and the production of human Lp(a). Female Lp(a)+; Gulo(-/-) and control wild-type Balb/c mice without these two metabolic features were orthotopically inoculated with 4T1 breast cancer cells (5x105). The transgenic and control mice were divided into 4 different dietary groups in respect to dietary vitamin C intake: i) low ascorbate intake for 6 weeks; ii) high ascorbate intake for 6 weeks; iii) low ascorbate intake for 3 weeks followed by high ascorbate for 3 weeks; iv) high ascorbate intake for 3 weeks followed by low ascorbate for 3 weeks. After 6 weeks, all wild-type mice developed tumors. In contrast, Lp(a)+; Gulo(-/-) mice developed one third less primary tumors (low ascorbate diet) or no primary tumors at all (high ascorbate diet). Significantly, tumors from Lp(a)+; Gulo(-/-) mice immunostained positively for Lp(a) and their size was inversely proportional to Lp(a) serum levels. The results implicate that Lp(a) may play a role in controlling tumor growth and expansion. The most likely mechanism is the competitive inhibition of plasmin-induced ECM degradation due to the homology of Lp(a) components to plasminogen. The confirmation of this pathomechanism could lead to a universal therapeutic target for the prevention and treatment of cancer.Keywords
This publication has 12 references indexed in Scilit:
- Hypoascorbemia induces atherosclerosis and vascular deposition of lipoprotein(a) in transgenic mice.2015
- Ascorbate supplementation inhibits growth and metastasis of B16FO melanoma and 4T1 breast cancer cells in vitamin C-deficient miceInternational Journal of Oncology, 2012
- Low Lipoprotein(a) Concentration Is Associated with Cancer and All-Cause Deaths: A Population-Based Cohort Study (The JMS Cohort Study)PLOS ONE, 2012
- Lipoprotein[a] and cancer: Anti-neoplastic effect besides its cardiovascular potencyCancer Treatment Reviews, 2007
- Angiostatin's molecular mechanism: Aspects of specificity and regulation elucidatedJournal of Cellular Biochemistry, 2005
- Urokinase Plasminogen Activator SystemClinical Orthopaedics and Related Research, 2003
- Inhibition of Angiogenesis and Angiogenesis-dependent Tumor Growth by the Cryptic Kringle Fragments of Human Apolipoprotein(a)Journal of Biological Chemistry, 2003
- Apolipoprotein(a), a Link between Atherosclerosis and Tumor AngiogenesisBiochemical and Biophysical Research Communications, 1999
- Hypothesis: lipoprotein(a) is a surrogate for ascorbate.Proceedings of the National Academy of Sciences, 1990
- The Mysteries Of Lipoprotein(a)Science, 1989